Posters Presented in 2013

ASCO IST-CAR-516 Poster

Results of a phase 1/2 study (NCT01365559) of carfilzomib (CFZ) replacing bortezomib (BTZ) in BTZ-containing regimens for BTZ-treated patients (pts) with relapsed and refractory multiple myeloma (MM)

Download Results of this Study


ASCO POM-DEX Poster

A Phase 1/2 Study (NCT01541332) of Pomalidomide (POM), Dexamethasone (DEX) and Pegylated Liposomal Doxorubicin (PLD) for
Patients with Relapsed/Refractory (R/R) Multiple Myeloma (MM)

POM-DEX ASCO

Download Results of this Study